PTP4A2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.5373999995294E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.97619999650922E-08 |
Normal-vs-Stage2 |
1.017590E-04 |
Normal-vs-Stage3 |
1.09420000005134E-06 |
Normal-vs-Stage4 |
3.004500E-04 |
Stage1-vs-Stage2 |
6.126400E-01 |
Stage1-vs-Stage3 |
6.891000E-01 |
Stage1-vs-Stage4 |
1.770430E-01 |
Stage2-vs-Stage3 |
8.380400E-01 |
Stage2-vs-Stage4 |
5.679200E-01 |
Stage3-vs-Stage4 |
3.467600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.88449999949781E-07 |
Normal-vs-AfricanAmerican |
1.48000500743706E-11 |
Normal-vs-Asian |
2.461800E-01 |
Caucasian-vs-AfricanAmerican |
3.94729999997345E-06 |
Caucasian-vs-Asian |
4.287600E-01 |
AfricanAmerican-vs-Asian |
1.109000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.37180000043303E-07 |
Normal-vs-Female |
2.96640000341242E-08 |
Male-vs-Female |
1.172570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.020640E-03 |
Normal-vs-Age(41-60Yrs) |
3.17959999995843E-07 |
Normal-vs-Age(61-80Yrs) |
6.09680000041024E-07 |
Normal-vs-Age(81-100Yrs) |
5.99789999999878E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.394400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.845200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.578200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.096000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.118800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.011000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.10199999999272E-05 |
Normal-vs-Grade 2 |
2.27939999986049E-07 |
Normal-vs-Grade 3 |
2.65840000013284E-08 |
Normal-vs-Grade 4 |
7.217100E-03 |
Grade 1-vs-Grade 2 |
4.451000E-01 |
Grade 1-vs-Grade 3 |
7.295200E-01 |
Grade 1-vs-Grade 4 |
2.468000E-02 |
Grade 2-vs-Grade 3 |
2.856600E-01 |
Grade 2-vs-Grade 4 |
3.746100E-02 |
Grade 3-vs-Grade 4 |
8.856600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.46359999675383E-08 |
Normal-vs-ccB subtype |
5.73269999999404E-05 |
ccA subtype-vs-ccB subtype |
1.522720E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.62219999999947E-07 |
Normal-vs-N1 |
4.656600E-01 |
N0-vs-N1 |
1.755970E-01 |
|
|